Document Detail


Orthostatic side effects of clomipramine and moclobemide during treatment for depression.
MedLine Citation:
PMID:  16195134     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
From a clinical point of view, orthostatic hypotension is a significant side effect during antidepressant treatment, particularly in the case of tricyclic antidepressants (TCAs). This prospective, randomized clinical trial evaluated the effects of clomipramine and moclobemide on orthostatic blood pressure during treatment for depression. One hundred and fifteen depressed inpatients, age up to 70 years, were randomized to treatment with either moclobemide (400 mg/day) or clomipramine (150 mg/day) after 1 week of placebo treatment. Orthostatic blood pressure was measured weekly over the 6-week study period. Clomipramine, but not moclobemide, caused a statistically significant fall in systolic (F = 9.37, P = 0.0037) and diastolic orthostatic blood pressure (F = 3.74, P = 0.0017). In the clomipramine-treated group of patients, we found no correlation between subjective complaints of orthostatic dizziness and the size of systolic orthostatic blood pressure. In conclusion, this study indicates that moclobemide does not induce orthostatic side effects, which is a significant problem in treatment with TCAs. However, the choice of antidepressants depends on other factors as well, e.g. the therapeutic efficacy.
Authors:
Kurt Bjerregaard Bjerregaard Stage;
Related Documents :
19480734 - Arterial baroreflex function in older adults with neurocardiogenic syncope.
2092964 - Haemodynamic effects of the multiple action antihypertensive drug urapidil.
12507804 - Resolution of vital sign instability: an objective measure of medical stability in anor...
15795694 - Impairment in orthostatic tolerance during heat exposure in individuals with type i and...
23656904 - Dietary glycine and blood pressure: the international study on macro/micronutrients and...
21904284 - Systolic right ventricular adaptive changes in athletes as predictors of the maximal fu...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Nordic journal of psychiatry     Volume:  59     ISSN:  0803-9488     ISO Abbreviation:  Nord J Psychiatry     Publication Date:  2005  
Date Detail:
Created Date:  2005-09-30     Completed Date:  2006-03-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100927567     Medline TA:  Nord J Psychiatry     Country:  Norway    
Other Details:
Languages:  eng     Pagination:  298-301     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, Odense University Hospital, DK-5000, Odense C, Denmark. kurtstage@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antidepressive Agents / adverse effects*,  therapeutic use
Clomipramine / adverse effects*,  therapeutic use
Depressive Disorder, Major / drug therapy*
Drug Administration Schedule
Female
Humans
Hypotension, Orthostatic / chemically induced*,  diagnosis
Male
Middle Aged
Moclobemide / adverse effects*,  therapeutic use
Prospective Studies
Severity of Illness Index
Chemical
Reg. No./Substance:
0/Antidepressive Agents; 303-49-1/Clomipramine; 71320-77-9/Moclobemide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Do individuals with former amphetamine dependence have cognitive deficits?
Next Document:  Quality of life in people with severe mental illness. Reliability and validity of the Manchester Sho...